Collectively, high expression of A2bR on RCC cell provides us new understandings of the role of adenosine receptor in tumor progression and blockade of adenosine A2b receptor may act as a promising candidate for therapeutic intervention for renal cell carcinoma. The gene discussed is ADORA2B; the disease is renal cell carcinoma.